High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 11 March 2019 |
| Author/s |
author: Mark Cook Chris Winearls Katja Weisel |
| Publication date | March 11, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |